Completed OBSERVATIONAL NCT06799468
Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation (TRAIN-AI)
Validation of the TRAIN-AI Score for the Prediction of Hepatocellular Carcinoma Recurrence After Liver Transplantation
Sponsor: European Hepatocellular Cancer Liver Transplant Group
Interventions
liver transplantation
Updated 1 time since 2025 Last updated: Jan 23, 2025 Started: Jan 1, 2003 Primary completion: Jan 1, 2003 Completion: Dec 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Deep Learning Model and Hepatocellular Carcinoma (HCC), this trial is completed. The trial is conducted by European Hepatocellular Cancer Liver Transplant Group and has accumulated 1 data snapshot since 2003. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- European Hepatocellular Cancer Liver Transplant Group
Data source: European Hepatocellular Cancer Liver Transplant Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.